JPWO2023204278A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023204278A5 JPWO2023204278A5 JP2024516313A JP2024516313A JPWO2023204278A5 JP WO2023204278 A5 JPWO2023204278 A5 JP WO2023204278A5 JP 2024516313 A JP2024516313 A JP 2024516313A JP 2024516313 A JP2024516313 A JP 2024516313A JP WO2023204278 A5 JPWO2023204278 A5 JP WO2023204278A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- atom
- group
- disease
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 239000000126 substance Substances 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 102000004127 Cytokines Human genes 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 229910052731 fluorine Inorganic materials 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 239000002184 metal Substances 0.000 claims 2
- 230000004048 modification Effects 0.000 claims 2
- 238000012986 modification Methods 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 102000019034 Chemokines Human genes 0.000 claims 1
- 108010012236 Chemokines Proteins 0.000 claims 1
- 102000014150 Interferons Human genes 0.000 claims 1
- 108010050904 Interferons Proteins 0.000 claims 1
- 102000015696 Interleukins Human genes 0.000 claims 1
- 108010063738 Interleukins Proteins 0.000 claims 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
- 102000015736 beta 2-Microglobulin Human genes 0.000 claims 1
- 108010081355 beta 2-Microglobulin Proteins 0.000 claims 1
- 230000010261 cell growth Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003792 electrolyte Substances 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 230000003394 haemopoietic effect Effects 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 229940047124 interferons Drugs 0.000 claims 1
- 229940047122 interleukins Drugs 0.000 claims 1
- 102000003390 tumor necrosis factor Human genes 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022070348 | 2022-04-21 | ||
| JP2022112701 | 2022-07-13 | ||
| PCT/JP2022/037909 WO2023203791A1 (ja) | 2022-04-21 | 2022-10-11 | 医薬組成物、吸着方法、治療方法および予防方法 |
| JP2022163375 | 2022-10-11 | ||
| PCT/JP2023/015821 WO2023204278A1 (ja) | 2022-04-21 | 2023-04-20 | 医薬組成物、吸着方法、治療方法および予防方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023204278A1 JPWO2023204278A1 (https=) | 2023-10-26 |
| JPWO2023204278A5 true JPWO2023204278A5 (https=) | 2024-12-25 |
Family
ID=88419979
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516314A Pending JPWO2023204279A1 (https=) | 2022-04-21 | 2023-04-20 | |
| JP2024516313A Pending JPWO2023204278A1 (https=) | 2022-04-21 | 2023-04-20 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516314A Pending JPWO2023204279A1 (https=) | 2022-04-21 | 2023-04-20 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20250032694A1 (https=) |
| EP (1) | EP4491187A4 (https=) |
| JP (2) | JPWO2023204279A1 (https=) |
| CN (2) | CN119031922A (https=) |
| WO (2) | WO2023204279A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120305284A (zh) * | 2024-01-12 | 2025-07-15 | 株式会社村田制作所 | 药物组合物、肠道菌群的改善方法、治疗方法和预防方法 |
| WO2025225525A1 (ja) * | 2024-04-26 | 2025-10-30 | 株式会社村田製作所 | 導電性粒子、フィルム、ペースト、コンポジット材料、および導電性粒子の製造方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11278862B2 (en) * | 2017-08-01 | 2022-03-22 | Drexel University | Mxene sorbent for removal of small molecules from dialysate |
| CN112316157A (zh) * | 2020-11-12 | 2021-02-05 | 苏州北科纳米科技有限公司 | 一种抗氧化MXenes材料的制备方法及应用 |
| CN115531411B (zh) * | 2022-09-19 | 2023-09-01 | 中南大学湘雅医院 | 一种具备ct成像和治疗双重作用的药物及其制备方法和应用 |
| WO2024101159A1 (ja) * | 2022-11-08 | 2024-05-16 | 株式会社村田製作所 | 医薬組成物、吸着方法、治療方法および予防方法 |
-
2023
- 2023-04-20 EP EP23791926.1A patent/EP4491187A4/en active Pending
- 2023-04-20 JP JP2024516314A patent/JPWO2023204279A1/ja active Pending
- 2023-04-20 CN CN202380034747.6A patent/CN119031922A/zh active Pending
- 2023-04-20 WO PCT/JP2023/015824 patent/WO2023204279A1/ja not_active Ceased
- 2023-04-20 JP JP2024516313A patent/JPWO2023204278A1/ja active Pending
- 2023-04-20 WO PCT/JP2023/015821 patent/WO2023204278A1/ja not_active Ceased
- 2023-04-20 CN CN202380034701.4A patent/CN119031979A/zh active Pending
-
2024
- 2024-10-15 US US18/915,818 patent/US20250032694A1/en active Pending
- 2024-10-18 US US18/919,892 patent/US20250041331A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2455559A1 (en) | Methods to mobilize progenitor/stem cells | |
| CN1202865C (zh) | 增效组合物 | |
| JP2021074025A5 (https=) | ||
| CN1140272C (zh) | 抗肿瘤剂 | |
| CA2433368A1 (en) | Adsorbent for oral administration | |
| CA2277365A1 (en) | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 | |
| JP2025157552A5 (https=) | ||
| JP2013501718A5 (https=) | ||
| JP2023058678A5 (https=) | ||
| JP2005538935A5 (https=) | ||
| JP2022000060A5 (https=) | ||
| JP2002543144A5 (https=) | ||
| JP2006502117A5 (https=) | ||
| WO2004043392B1 (en) | Mucin synthesis inhibitors | |
| CN1054509C (zh) | 淋巴激活素和双链rna的增效作用 | |
| JPWO2023204278A5 (https=) | ||
| JPWO2023204279A5 (https=) | ||
| US3826823A (en) | Stabilized prostaglandin preparations | |
| WO1999018993A1 (en) | Ameliorant for hepatitis c remedial effect and application thereof | |
| JP2002542256A5 (https=) | ||
| JP2688057B2 (ja) | 抗腺がん剤 | |
| CN114469992A (zh) | 钼基多金属氧酸盐簇在治疗炎性疾病中的应用 | |
| Zamkoff et al. | A phase I trial of recombinant human macrophage colony-stimulating factor by rapid intravenous infusion in patients with refractory malignancy | |
| JPWO2024101159A5 (https=) | ||
| JP2004506605A5 (https=) |